STAGE 0 OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8

Clinical trials for STAGE 0 OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8 explained in plain language.

Never miss a new study

Get alerted when new STAGE 0 OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8 trials appear

Sign up with your email to follow new studies for STAGE 0 OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to shield cancer patients from painful mouth sores

Symptom relief Recruiting now

This study is testing if adding an investigational drug called BMX-001 to standard symptom care can better prevent severe mouth sores in people receiving combined chemotherapy and radiation for head and neck cancer. About 98 participants will be randomly assigned to receive eithe…

Matched conditions: STAGE 0 OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8

Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief

Last updated Mar 16, 2026 15:26 UTC

STAGE 0 OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8

Get alerted when new STAGE 0 OROPHARYNGEAL (P16-NEGATIVE) CARCINOMA AJCC V8 trials appear

New drug aims to shield cancer patients from painful mouth sores